Inflammatory debate: The brave new world of rheumatoid arthritis management

Charlotte Wood, Treasure M. McGuire*

*Corresponding author for this work

Research output: Contribution to journalMagazine ArticleResearch


IT IS A chronic, autoimmune disease where inflammation of synovial tissue in peripheral joints leads to progressive and irreversible joint destruction, loss of mobility and pain. Primary targets are metatarsophalangeal and metacarpophalangeal joints, with later involvement of medium size joints -- e.g. ankles and wrists and larger joints such as knees. Joint pain and stiffness is worse on waking and can be relieved by activity. Typical systemic symptoms include malaise, fever, weight loss and anorexia.
Original languageEnglish
Pages (from-to)17-19
Number of pages3
JournalPharmacy News
Issue number10/MAY
Publication statusPublished - 10 May 2007


Dive into the research topics of 'Inflammatory debate: The brave new world of rheumatoid arthritis management'. Together they form a unique fingerprint.

Cite this